Johanna Flting - BioArctic VP Research

BIOA-B Stock  SEK 210.20  6.60  3.24%   

Insider

Johanna Flting is VP Research of BioArctic AB
Age 51
Phone46 86 95 69 30
Webhttps://www.bioarctic.se

BioArctic Management Efficiency

BioArctic's management efficiency ratios could be used to measure how well BioArctic manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 7.79 M in total debt with debt to equity ratio (D/E) of 3.0, implying the company greatly relies on financing operations through barrowing. BioArctic AB has a current ratio of 5.51, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist BioArctic until it has trouble settling it off, either with new capital or with free cash flow. So, BioArctic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioArctic AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioArctic to invest in growth at high rates of return. When we think about BioArctic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Klaus SindahlHansa Biopharma AB
N/A
Sren MScHansa Biopharma AB
58
Emanuel BjrneHansa Biopharma AB
50
Cecilia HofvanderBioInvent International AB
56
Susanne AhlbergGenovis AB
66
Claus BisgaardVitrolife AB
46
RGN MScBioInvent International AB
N/A
Ricardo CapellaVitrolife AB
55
Katja MargellHansa Biopharma AB
N/A
Patrik TolfVitrolife AB
53
BA BAGenovis AB
N/A
Rikke RytterGenovis AB
56
Magnus LangbergGenovis AB
52
Daniel ForssVitrolife AB
51
Linda AnderssonGenovis AB
47
Bjrn FrendusBioInvent International AB
50
Stefan MBABioInvent International AB
60
Anne LannerHansa Biopharma AB
54
Maria EdholmGenovis AB
N/A
Fredrik OlssonGenovis AB
52
Karin RussbergVitrolife AB
54
BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden. BioArctic AB (BIOA-B) is traded on Stockholm Exchange in Sweden and employs 61 people.

Management Performance

BioArctic AB Leadership Team

Elected by the shareholders, the BioArctic's board of directors comprises two types of representatives: BioArctic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioArctic. The board's role is to monitor BioArctic's management team and ensure that shareholders' interests are well served. BioArctic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioArctic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gunilla Andersson, Director HR
Pr Gellerfors, Sr CoFounder
Jan Mattsson, S Fin
Christer Mller, VP Officer
Gunilla Osswald, Chief Officer
Pr Lannfelt, VP CoFounder
Oskar Bosson, VP IR
Frida Lekander, Head Marketing
Johanna Flting, VP Research
Harald Borgeke, Head Affairs

BioArctic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioArctic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioArctic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioArctic's short interest history, or implied volatility extrapolated from BioArctic options trading.

Pair Trading with BioArctic

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioArctic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioArctic will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioArctic Stock

  0.75VITR Vitrolife ABPairCorr

Moving against BioArctic Stock

  0.73BINV BioInvent InternationalPairCorr
  0.73HM-B H M HennesPairCorr
  0.59NDA-SE Nordea Bank AbpPairCorr
  0.54TELIA Telia CompanyPairCorr
The ability to find closely correlated positions to BioArctic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioArctic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioArctic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioArctic AB to buy it.
The correlation of BioArctic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioArctic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioArctic AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioArctic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioArctic AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for BioArctic Stock analysis

When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Please note, there is a significant difference between BioArctic's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioArctic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioArctic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.